Evidence map›Paper›PMID 39524451›Full record

ArticleFrontiers in immunology2024

Elevated circulating group-2 innate lymphoid cells expressing activation markers and correlated tryptase AB1 levels in active ascariasis.

Juan-Felipe López, Josefina Zakzuk, Pattraporn Satitsuksanoa, Ana Lozano, Laura Buergi, Anja Heider, Juan Carlos Alvarado-Gonzalez, Huseyn Babayev, Cezmi Akdis, Willem van de Veen and 2 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Frontiers in medicine · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Juan-Felipe LópezSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Josefina ZakzukInstitute for Immunological Research, University of Cartagena, Cartagena, Colombia.
Pattraporn SatitsuksanoaSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Ana LozanoInstitute for Immunological Research, University of Cartagena, Cartagena, Colombia.
Laura BuergiSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Anja HeiderSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Juan Carlos Alvarado-GonzalezInstitute for Immunological Research, University of Cartagena, Cartagena, Colombia.
Huseyn BabayevSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Cezmi AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Willem van de VeenSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
Luis CaraballoInstitute for Immunological Research, University of Cartagena, Cartagena, Colombia.
Mübeccel AkdisSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: Non-infected (NI; n=16) and Ascaris-infected (AI; n=16) subjects from an endemic area were included. Two consecutive stool samples from each subject were examined by Kato-Katz to define parasite infection. Antibodies to the ABA-1 antigen of Ascaris and Ascaris extract were measured by ELISA. ILC subsets and their activation markers (CD25, CD69, thymic stromal lymphopoietin receptor (TSLPR) were evaluated in its PBMC by flow cytometry. Proximity extension assay (PEA) was performed to explore plasma proteins associated to infection. Results: No significant differences in the relative or absolute frequencies of total ILCs, ILC1, ILC2 and ILC3 cells were observed regarding the infection status. However, within AI group, IgE-sensitized subjects to ABA-1 had higher frequencies and counts of ILC2 (p<0.05). Frequencies of CD25+, CD69+ and TSLPR+ ILC2 were higher in AI compared to the NI (p<0.01). Additionally, egg burden was positively correlated with CD69+ ILC2 frequencies (r=0.67; p=0.005). Tryptase alpha/beta 1 (TPSAB1), GP6 and several plasma proteins associated with cell growth and granulocyte chemotaxis were highly expressed in the AI group (p<0.05). Interestingly, TPSAB1 levels were positively correlated with ILC2 expressing activation markers frequencies, egg burden and IgE levels against Ascaris. Discussion: Ascaris infection is associated with increased expression of ILC2 activation markers and TPSAB1, which may contribute to the type-2 response.

Indexed as

AscariasisBiomarkersImmunity, InnateLymphocytesTryptasesAdultAnimalsAntibodies, HelminthAscaris lumbricoidesFemaleHumansMaleMiddle AgedYoung AdultAntibodies, HelminthBiomarkersTryptasesascariasishelminthIgEimmune regulationinnate lymphoid cellsTryptase AB1type-2 immunity

Identifiers

PMID39524451
PMCPMC11549673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.